Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey
Language English Country United States Media print
Document type Journal Article
PubMed
36373291
DOI
10.3233/jnd-221525
PII: JND221525
Knihovny.cz E-resources
- Keywords
- Covid-19, Europe, Telemedicine, neuromuscular diseases,
- MeSH
- COVID-19 * MeSH
- Humans MeSH
- Neuromuscular Diseases * MeSH
- Pandemics MeSH
- SARS-CoV-2 MeSH
- Aged MeSH
- Telemedicine * methods MeSH
- Check Tag
- Humans MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Telemedicine (TM) contributes to bridge the gap between healthcare facilities and patients' homes with neuromuscular disease (NMD) because of mobility issues. However, its deployment is limited due to difficulties evaluating subtle neurological signs such as mild weakness or sensory deficits. The COVID-19 pandemic has disrupted healthcare delivery worldwide, necessitating rapid measures implementation by health care providers (HCPs) to protect patients from acquiring SARS-CoV-2 while maintaining the best care and treatment. OBJECTIVES: Given the challenges faced by remote healthcare assistance of NMD patients, we aim to evaluate the use of TM in NMD during the COVID-19 pandemic. METHODS: Based on the Model for Assessment-of-Telemedicine-Applications (MAST), we conducted a survey amongst clinicians of the ERN EURO NMD (European-Reference-Network-for-Rare-Neuromuscular-Diseases). RESULTS: Based on 42 responses over 76 expected ones, our results show that the COVID-19 pandemic significantly increased the number of HCPs using TM (from 60% to 100%). The TM types most used during the COVID-19 period are teleconsultation and consultation by phone, particularly in the context of symptoms worsening in NMD patients with COVID-19 infection. Most European HCPs were satisfied when using TM but as a complementary option to physical consultations. Many responses addressed the issue of technical aspects needing improvement, particularly for elderly patients who need caregivers' assistance for accessing the TM platform. CONCLUSIONS: TM has been essential during COVID-19, but its use still presents some limitations for NMD patients with cognitive deficits or for first-time diagnosis. Thus, TM should be used as complement to, rather than substitute, for face-to-face consultations.
Amsterdam University Medical Centres Academic Medical Centre Amsterdam The Netherlands
Centre de Référence des Maladies Neuromusculaires et de la SLA APHM CHU Timone Marseille France
Centro di Riferimento Regionale perla Ricerca Neurology and Neuromuscular Diseases Unit Italy
Clinic for Pediatrics 1 Pediatric Neurology University Hospital Essen Essen Germany
Department of Clinical and Experimental Medicine University of Pisa Pisa Italy
Department of Neurology Erasmus MC University Medical Center Rotterdam The Netherlands
Department of Neurology Klinikum München Friedrich Baur Institut München Germany
Department of Neurology Leiden University Medical Centre Leiden The Netherlands
Department of Neurology Maastricht University Medical Center Maastricht The Netherlands
Department of Neurology Radboud University Medical Centre GA Nijmegen The Netherlands
Department of Neurology University Hospital Brno Brno Czech Republic
Department of Neurology University of Pécs Pécs Hungary
Department of Pediatric Neurology Charité Universitätsmedizin Berlin Berlin Germany
Department of Pediatric Neurology Motol University Hospital Prague Czech Republic
Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy
Institute of Clinical Neurophysiology University Medical Centre Ljubljana Ljubljana Slovenia
Institute of Genomic Medicine and Rare Disorders Semmelweis University Budapest Hungary
Muscle Research Unit Experimental and Clinical Research Center Charit Germany
Netherlands Institute for Health Services Research Utrecht The Netherlands
Neurology Department Bucharest University and Emergency Hospital Bucharest Romania
Neurology Department CHU Henri Mondor APHP UPEC Créteil France
Neuromuscular Omnicentre Fondazione Serena Onlus Milan Italy
Neuromuscular Unit Neurology Department Hospital de Sant Pau IIB Sant Pau Barcelona Spain
Unit of Neurology San Luca Hospital Via Lippi Francesconi Lucca Italy
References provided by Crossref.org